Processing

Please wait...

Settings

Settings

Goto Application

1. WO2000032199 - USE OF GALANTHAMINE AND GALANTHAMINE DERIVATIVES IN THE CASE OF ACUTE FUNCTIONAL BRAIN DAMAGE

Publication Number WO/2000/032199
Publication Date 08.06.2000
International Application No. PCT/AT1998/000291
International Filing Date 01.12.1998
Chapter 2 Demand Filed 03.07.2000
IPC
A61K 31/55 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
55having seven-membered rings, e.g. azelastine, pentylenetetrazole
CPC
A61K 31/55
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
55having seven-membered rings, e.g. azelastine, pentylenetetrazole
Applicants
  • SANOCHEMIA PHARMAZEUTIKA AKTIENGESELLSCHAFT [AT]/[AT] (AllExceptUS)
  • MUCKE, Martin, Alois, Hermann [AT]/[AT] (UsOnly)
  • FRÖHLICH, Johannes [AT]/[AT] (UsOnly)
  • JORDIS, Ulrich [AT]/[AT] (UsOnly)
Inventors
  • MUCKE, Martin, Alois, Hermann
  • FRÖHLICH, Johannes
  • JORDIS, Ulrich
Agents
  • BEER, Manfred
Priority Data
Publication Language German (DE)
Filing Language German (DE)
Designated States
Title
(DE) VERWENDUNG VON GALANTHAMIN UND GALANTHAMINDERIVATEN BEI AKUTEN FUNKTIONELLEN HIRNSCHÄDEN
(EN) USE OF GALANTHAMINE AND GALANTHAMINE DERIVATIVES IN THE CASE OF ACUTE FUNCTIONAL BRAIN DAMAGE
(FR) UTILISATION DE GALANTHAMINE ET DE DERIVES DE GALANTHAMINE EN CAS DE LESIONS CEREBRALES FONCTIONNELLES AIGUES
Abstract
(DE)
Verwendung von Galanthamin und Analoga desselben oder Säureadditionssalzen hiervon zum Herstellen von Arzneimitteln für die Behandlung des Zustandes nach Schlaganfall oder des geschlossenen fokalen Schädel-Hirn-Traumas oder des Schleudertraumas.
(EN)
The invention relates to the use of galanthamine and analogs thereof or acidic addition salts thereof in the production of medicaments for treating states arising from cerebro-vascular accidents or closed focal craniocerebral traumas or whiplash injuries.
(FR)
Utilisation de galanthamine et d'analogues de celle-ci ou bien de ses sels d'addition d'acide pour la fabrication de médicaments destinés au traitement de l'état post-apoplexie cérébral ou du traumatisme craniocérébral focal fermé ou bien du traumatisme par projection.
Also published as
Latest bibliographic data on file with the International Bureau